Masimo

Yahoo Finance • 14 days ago

Masimo Corporation (MASI): A Bull Case Theory

We came across a bullish thesis on Masimo Corporation on HatedMoats’s Substack. In this article, we will summarize the bulls’ thesis on MASI. Masimo Corporation's share was trading at $142.13 as of September 22nd. MASI’s trailing P/E were... Full story

Yahoo Finance • 25 days ago

MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASI

NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Masimo... Full story

Yahoo Finance • last month

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies

September 11, 2025 Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaborat... Full story

Yahoo Finance • last month

Masimo Announces Expansion of Strategic Partnership with Philips

Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions IRVINE, Calif., September 11, 2025--(BUSINESS WIRE)--Masimo (NAS... Full story

Yahoo Finance • last month

Apple Watch (AAPL) Blood Oxygen Feature Reintroduced in US After Legal Battle

Apple Inc. (NASDAQ:AAPL) is placed 4th on our list of the best stocks to buy. On August 14, Apple announced that it is restoring the blood oxygen tracking feature on Apple Watches in the US after settling a long legal battle with Masimo Co... Full story

Yahoo Finance • 2 months ago

US Customs sued by Masimo over approval of Apple Watch imports with blood oxygen feature

[Apple Store at 5th Ave in Manhattan, New York City] ozgurdonmaz/iStock Unreleased via Getty Images Masimo (NASDAQ:MASI [https://seekingalpha.com/symbol/MASI]) filed a lawsuit against U.S. Customs and Border Protection over a decision tha... Full story

Yahoo Finance • 2 months ago

Masimo sues US Customs over approval of Apple Watch imports

By Blake Brittain WASHINGTON (Reuters) -Medical monitoring technology company Masimo (NASDAQ:MASI) sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple (NASDAQ:AAPL) to import Apple Watches... Full story

Yahoo Finance • 2 months ago

Masimo receives FDA clearance for expanded O3 oximetry parameters

IRVINE, Calif. - Masimo (NASDAQ:MASI), a medical technology company with a market capitalization of $8.36 billion, has received FDA 510(k) clearance for expanded indications of its delta hemoglobin parameters provided with O3 Regional Oxim... Full story

Yahoo Finance • 2 months ago

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling

Apple Inc. (NASDAQ:AAPL) will introduce a redesigned Blood Oxygen feature for some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users through an iPhone and Apple Watch software update later on Thursday. Users with these models... Full story

Yahoo Finance • 2 months ago

Apple to bring blood oxygen feature to some US watches with software update

By Stephen Nellis SAN FRANCISCO (Reuters) -Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the U.S. government amid a protracted legal dispute over the te... Full story

Yahoo Finance • 2 months ago

Jeremy Grantham's Strategic Moves: Significant Reduction in Otis Worldwide Corp

Exploring the Investment Shifts of a Renowned Value Investor Jeremy Grantham (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Jeremy Gra... Full story

Yahoo Finance • 2 months ago

Masimo Second Quarter 2025 Earnings: EPS Misses Expectations

Masimo (NASDAQ:MASI) Second Quarter 2025 Results Key Financial Results Revenue: US$370.9m (down 25% from 2Q 2024). Net income: US$44.9m (up 181% from 2Q 2024). Profit margin: 12% (up from 3.2% in 2Q 2024). EPS: US$0.83 (up from US$0.30 i... Full story

Yahoo Finance • 2 months ago

Masimo outlines 24–30% EPS growth for 2025 while advancing commercial strategy and tariff mitigation

Earnings Call Insights: Masimo Corporation (MASI) Q2 2025 MANAGEMENT VIEW * CEO Catherine M. Szyman reported "our core Healthcare business delivered strong growth and earnings performance. Revenue was $370 million, and we achieved earn... Full story

Yahoo Finance • 2 months ago

Masimo Corporation Announces Advance In Q2 Profit

(RTTNews) - Masimo Corporation (MASI) reported a profit for its second quarter that Increases, from last year The company's bottom line came in at $44.9 million, or $0.82 per share. This compares with $24.8 million, or $0.46 per share, l... Full story

Yahoo Finance • 2 months ago

Masimo  Non-GAAP EPS of $1.33 beats by $0.11, revenue of $370.3M beats by $1.65M

* Masimo press release [https://seekingalpha.com/pr/20190074-masimo-reports-second-quarter-2025-results] (NASDAQ:MASI [https://seekingalpha.com/symbol/MASI]): Q2 Non-GAAP EPS of $1.33 beats by $0.11. * Revenue of $370.3M (-25.4% Y/Y) b... Full story

Yahoo Finance • 2 months ago

What Makes Masimo Corporation (MASI) a Good Investment?

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a... Full story

Yahoo Finance • 3 months ago

Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the Firm

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, is investigating potential violations of federal and state laws by officers and directors of Elanco Animal Health Incorporated (NYSE: ELAN)... Full story

Yahoo Finance • 3 months ago

Neuraxis ends Masimo license agreement and launches employee stock plan

Neuraxis, Inc. (NYSE American:NRXS), a $23 million market cap healthcare company with annual revenue of $2.93 million and impressive year-over-year growth of 27.5%, disclosed on Thursday that it has terminated its license and collaboration... Full story

Yahoo Finance • 4 months ago

MASIMO CORPORATION INVESTIGATION ALERT: Johnson Fistel, PLLP Investigates Potential Breach of Fiduciary Duties by Masimo Officers and Directors

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Leading shareholder rights law firm Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duties by current and former directors and officers of Masimo Corporati... Full story